Geron Total Assets 2006-2019 | GERN

Geron total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Geron Annual Total Assets
(Millions of US $)
2018 $185
2017 $110
2016 $130
2015 $149
2014 $173
2013 $67
2012 $100
2011 $160
2010 $234
2009 $180
2008 $176
2007 $219
2006 $221
2005 $201
Geron Quarterly Total Assets
(Millions of US $)
Q3 2019 $164
Q2 2019 $166
Q1 2019 $176
Q4 2018 $185
Q3 2018 $188
Q2 2018 $183
Q1 2018 $106
Q4 2017 $110
Q3 2017 $114
Q2 2017 $124
Q1 2017 $129
Q4 2016 $130
Q3 2016 $136
Q2 2016 $137
Q1 2016 $143
Q4 2015 $149
Q3 2015 $154
Q2 2015 $159
Q1 2015 $166
Q4 2014 $173
Q3 2014 $144
Q2 2014 $149
Q1 2014 $155
Q4 2013 $67
Q3 2013 $69
Q2 2013 $73
Q1 2013 $83
Q4 2012 $100
Q3 2012 $111
Q2 2012 $126
Q1 2012 $141
Q4 2011 $160
Q3 2011 $188
Q2 2011 $200
Q1 2011 $217
Q4 2010 $234
Q3 2010 $162
Q2 2010 $171
Q1 2010 $181
Q4 2009 $180
Q3 2009 $193
Q2 2009 $200
Q1 2009 $212
Q4 2008 $176
Q3 2008 $188
Q2 2008 $201
Q1 2008 $211
Q4 2007 $219
Q3 2007 $218
Q2 2007 $228
Q1 2007 $229
Q4 2006 $221
Q3 2006 $182
Q2 2006 $191
Q1 2006 $194
Q4 2005 $201
Q3 2005 $210
Q2 2005 $138
Q1 2005 $136
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.290B $0.001B
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.901B 16.46
CSL (CSLLY) Australia $94.668B 0.00
Gilead Sciences (GILD) United States $79.957B 9.91
Vertex Pharmaceuticals (VRTX) United States $60.559B 61.81
Biogen (BIIB) United States $51.632B 8.86
Illumina (ILMN) United States $47.916B 52.57
Regeneron Pharmaceuticals (REGN) United States $42.333B 18.54
Alexion Pharmaceuticals (ALXN) United States $24.897B 12.30
Seattle Genetics (SGEN) United States $18.451B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.365B 40.31
BioMarin Pharmaceutical (BMRN) United States $16.010B 0.00
Genmab (GNMSF) Denmark $14.044B 62.03
Alnylam Pharmaceuticals (ALNY) United States $13.305B 0.00
Galapagos (GLPG) Belgium $12.398B 31.94
Exact Sciences (EXAS) United States $11.656B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.384B 54.64
BeiGene (BGNE) Cayman Islands $10.251B 0.00
Sarepta Therapeutics (SRPT) United States $9.713B 0.00
Bio-Techne Corp (TECH) United States $8.362B 55.97
Guardant Health (GH) United States $7.827B 0.00
QIAGEN (QGEN) Netherlands $7.710B 25.14
BioNTech SE (BNTX) Germany $7.297B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.172B 18.23
Amarin (AMRN) Ireland $7.166B 0.00
Moderna (MRNA) United States $7.002B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.863B 0.00
Reata Pharmaceuticals (RETA) United States $6.547B 0.00
Exelixis (EXEL) United States $6.211B 17.47
Ascendis Pharma (ASND) Denmark $5.919B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.718B 0.00
Bluebird Bio (BLUE) United States $5.393B 0.00
Repligen (RGEN) United States $5.201B 94.25
China Biologic Products (CBPO) China $4.606B 25.94
MorphoSys AG (MOR) Germany $4.252B 0.00
Blueprint Medicines (BPMC) United States $3.983B 0.00
Mirati Therapeutics (MRTX) United States $3.842B 0.00
Immunomedics (IMMU) United States $3.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
MyoKardia (MYOK) United States $3.475B 0.00
NeoGenomics (NEO) United States $3.404B 181.11
Adaptive Biotechnologies (ADPT) United States $3.403B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.292B 0.00
Alkermes (ALKS) Ireland $3.149B 0.00
Zai Lab (ZLAB) China $3.002B 0.00
Acceleron Pharma (XLRN) United States $2.986B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.978B 0.00
Halozyme Therapeutics (HALO) United States $2.950B 0.00
Genmab (GMAB) Denmark $2.938B 6.05
UniQure (QURE) Netherlands $2.907B 0.00
Emergent Biosolutions (EBS) United States $2.893B 28.74
Amicus Therapeutics (FOLD) United States $2.691B 0.00
Epizyme (EPZM) United States $2.326B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
RA PHARMCTL INC (RARX) United States $2.217B 0.00
Myriad Genetics (MYGN) United States $2.151B 31.78
Denali Therapeutics (DNLI) United States $2.123B 0.00
Insmed (INSM) United States $2.027B 0.00
Principia Biopharma (PRNB) United States $1.879B 0.00
Fate Therapeutics (FATE) United States $1.837B 0.00
REGENXBIO (RGNX) United States $1.807B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Arvinas (ARVN) United States $1.731B 0.00
Akcea Therapeutics (AKCA) United States $1.670B 0.00
Editas Medicine (EDIT) United States $1.643B 0.00
Ligand Pharmaceuticals (LGND) United States $1.625B 31.26
Intra-Cellular Therapies (ITCI) United States $1.476B 0.00
Innoviva (INVA) United States $1.470B 4.33
Dicerna Pharmaceuticals (DRNA) United States $1.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.424B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.409B 0.00
Coherus BioSciences (CHRS) United States $1.393B 0.00
Alector (ALEC) United States $1.371B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.197B 0.00
DBV Technologies S.A (DBVT) France $1.164B 0.00
Zealand Pharma (ZEAL) Denmark $1.149B 0.00
Codexis (CDXS) United States $1.087B 0.00
Sangamo Therapeutics (SGMO) United States $1.025B 0.00
Revance Therapeutics (RVNC) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.902B 0.00
Heska (HSKA) United States $0.833B 212.78
Mesoblast (MESO) Australia $0.829B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.825B 6.94
Cellectis S.A (CLLS) France $0.783B 0.00
Vericel (VCEL) United States $0.779B 290.50
GENFIT S.A (GNFT) France $0.777B 0.00
Twist Bioscience (TWST) United States $0.765B 0.00
Adverum Biotechnologies (ADVM) United States $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.745B 0.00
Intellia Therapeutics (NTLA) United States $0.741B 0.00
ANI Pharmaceuticals (ANIP) United States $0.739B 12.61
Sorrento Therapeutics (SRNE) United States $0.727B 0.00
NantKwest (NK) United States $0.726B 0.00
UROGEN PHARMA (URGN) United States $0.723B 0.00
Retrophin (RTRX) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Cara Therapeutics (CARA) United States $0.676B 0.00
Anika Therapeutics (ANIK) United States $0.672B 21.81
AC Immune SA (ACIU) Switzerland $0.656B 15.17
Prothena (PRTA) Ireland $0.614B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.581B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.541B 0.00
Agenus (AGEN) United States $0.529B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Dynavax Technologies (DVAX) United States $0.517B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.516B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.509B 0.00
Arcus Biosciences (RCUS) United States $0.480B 0.00
Bellus Health (BLU) Canada $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.451B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 3.12
AnaptysBio (ANAB) United States $0.438B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.415B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Pfenex (PFNX) United States $0.397B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
Cue Biopharma (CUE) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
PDL BioPharma (PDLI) United States $0.375B 9.37
Avid Bioservices (CDMO) United States $0.368B 0.00
Mersana Therapeutics (MRSN) United States $0.364B 0.00
Cel-Sci (CVM) United States $0.353B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Puma Biotechnology (PBYI) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Inovio Pharmaceuticals (INO) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
VBI Vaccines (VBIV) United States $0.317B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
Compugen (CGEN) Israel $0.312B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
IVERIC Bio (ISEE) United States $0.279B 0.00
WAVE Life Sciences (WVE) Singapore $0.278B 0.00
Sutro Biopharma (STRO) United States $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
Kamada (KMDA) Israel $0.262B 7.65
Prometic Life Sciences (LMNL) Canada $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.244B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.225B 0.00
Cerecor (CERC) United States $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.217B 0.00
Exicure (XCUR) United States $0.213B 0.00
XOMA (XOMA) United States $0.209B 0.00
Athersys (ATHX) United States $0.201B 0.00
Fortress Biotech (FBIO) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Five Prime Therapeutics (FPRX) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.187B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.185B 0.00
Alcobra (ARCT) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
TELA Bio (TELA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Palatin Technologies (PTN) United States $0.167B 4.56
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Novavax (NVAX) United States $0.154B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
Applied Genetic Technologies (AGTC) United States $0.148B 0.00
Verastem (VSTM) United States $0.146B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 3.65
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Arsanis (XFOR) United States $0.128B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
BioTime (LCTX) United States $0.125B 6.43
Aptinyx (APTX) United States $0.121B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
OvaScience (MLND) United States $0.111B 0.00
Clearside Biomedical (CLSD) United States $0.110B 0.00
Antibe Therapeutics (ATBPF) Canada $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
Acorda Therapeutics (ACOR) United States $0.103B 0.00
Synlogic (SYBX) United States $0.103B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Trevena (TRVN) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.081B 5.23
Vaccinex (VCNX) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.030B 0.00
Novogen (KZIA) Australia $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Advaxis (ADXS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00